Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genmab A/S
Other Equity Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Other Equity
kr234m
CAGR 3-Years
42%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Other Equity
kr22.7m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Other Equity
-€329m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Other Equity
-kr16.5m
CAGR 3-Years
23%
CAGR 5-Years
15%
CAGR 10-Years
N/A
F
Fluoguide AS
STO:FLUO
Other Equity
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Other Equity
-kr84k
CAGR 3-Years
N/A
CAGR 5-Years
23%
CAGR 10-Years
N/A

See Also

What is Genmab A/S's Other Equity?
Other Equity
234m DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Other Equity amounts to 234m DKK.

What is Genmab A/S's Other Equity growth rate?
Other Equity CAGR 5Y
20%

Over the last year, the Other Equity growth was 109%. The average annual Other Equity growth rates for Genmab A/S have been 42% over the past three years , 20% over the past five years .

Back to Top